作者: Ofer Wiser , Belmaker Lior Ann Rosenberg , Osnat Bohana-Kashtan
DOI:
关键词:
摘要: A method of qualifying whether a cell population is suitable therapeutic for treating an eye condition disclosed. The comprises analyzing co-expression premelanosome protein (PMEL17) and at least one polypeptide selected from the group consisting cellular retinaldehyde binding (CRALBP), lecithin retinol acyltransferase (LRAT) sex determining region Y-box 9 (SOX 9) in cells.